Clinical Trial Update: Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial compares immunotherapy plus capecitabine versus capecitabine alone in advanced breast cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Immunotherapy (immunotherapy)

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING